secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001437749-22-000622
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology CEO to present at investor conferences beginning Jan 10, 2022
--------------------------------------------------------------------------------

- CEO Alan Auerbach will present at conferences and other forums starting January 10, 2022.
- Presentation slides attached as Exhibit 99.1 contain the information to be disclosed.
- No specific financial or operational details from the slides are available in this filing text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922000622/0001437749-22-000622-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922000622/pbyi20220106_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-000622

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer